Compare Canopy Growth Corp (CGC) vs Schlumberger NV (SLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canopy Growth Corp vs Schlumberger NV — how do they compare? Canopy Growth Corp trades at $1.02 (market cap $430.60M), while Schlumberger NV trades at $52.24 (market cap $78.08B). The key difference: Schlumberger NV is far larger — about 181.3× Canopy Growth Corp's market cap, and Schlumberger NV pays a 2.24% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| CGC | SLB | |
|---|---|---|
Market Cap | $430.60M | $78.08B |
Sector | Health | Energy |
52-Week High | $1.92 | $58.01 |
52-Week Low | $0.86 | $31.72 |
Enterprise Value | $388.01M | $86.81B |
Dividend Yield | — | 2.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CGC trades at $1.01, up 1.0% in the last session, with a bullish technical signal from moving averages but overbought RSI readings. The company reported Q1 fiscal 2027 revenue growth of 13% year-over-year, beating estimates, yet continues to post net losses. Recent news highlights expansion in European medical cannabis markets and cost-cutting efforts, while analyst consensus is mixed with 33% buy ratings.
Outlook remains speculative with high execution risk; improving cash flow trends and potential U.S. rescheduling offer upside, but persistent negative margins and debt concerns weigh on equity value. Investors should weigh growth prospects against profitability challenges in the volatile cannabis sector.
SLB trades at $52.06, down 3.02% over 24 hours, with a bullish technical signal from moving averages. The company reported Q2 2026 EPS of $0.55, beating estimates, and maintains strong cash flow from operations of $6.49B in 2025. Revenue trends show resilience despite a slight dip to $35.71B in 2025, with profitability supported by an 8.53% net income margin.
Outlook remains positive with an 84.85% analyst buy rating and a $63.00 consensus price target, implying 21% upside. Risks include Middle East operational challenges and net cash outflows, but growth in digital and offshore segments offers opportunity. The stock's valuation at a P/E of 25.66 is reasonable given earnings momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Canopy Growth Corp
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →About Schlumberger NV
Schlumberger is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry's leading innovators, which has earned it dominant share in numerous end markets.
Read more on SLB →
